Emmecell

Emmecell Utilizes a Proprietary Magnetic Cell Delivery Nanoparticle Platform to Address the Challenges of Delivery, Retention, and Integration in Cell Therapy by Efficiently Targeting and Integrating Cell Therapies into the Appropriate Target Tissues Using Magnetic Nanoparticles. Emmecell Possesses an Extensive IP Portfolio and Initially Focuses Its Efforts on Ophthalmic Indications.